{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:15:30Z","timestamp":1785885330032,"version":"3.56.0"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T00:00:00Z","timestamp":1484006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012640","name":"ExxonMobil Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012640","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002212","type":"journal-article","created":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T19:23:43Z","timestamp":1485977023000},"page":"e1002212","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":71,"title":["Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis"],"prefix":"10.1371","volume":"14","author":[{"given":"Richard M.","family":"Hoglund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3433-6106","authenticated-orcid":true,"given":"Lesley","family":"Workman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Edstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Xuan","family":"Thanh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8703-0891","authenticated-orcid":true,"given":"Nguyen Ngoc","family":"Quang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issaka","family":"Zongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Bosco","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Borrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Mwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Nsanzabana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2000-2874","authenticated-orcid":true,"given":"Ric N.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2158-846X","authenticated-orcid":true,"given":"Prabin","family":"Dahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1333-4838","authenticated-orcid":true,"given":"Nancy C.","family":"Sambol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7951-0745","authenticated-orcid":true,"given":"Francois","family":"Nosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0383-9624","authenticated-orcid":true,"given":"Aung Pyae","family":"Phyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khin Maung","family":"Lwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1621-3257","authenticated-orcid":true,"given":"Rose","family":"McGready","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P. J.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6008-2963","authenticated-orcid":true,"given":"Philippe J.","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1897-1978","authenticated-orcid":true,"given":"Nicholas J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen I.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4566-4030","authenticated-orcid":true,"given":"Joel","family":"Tarning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,1,10]]},"reference":[{"key":"ref1","year":"2015"},{"key":"ref2","year":"2015"},{"issue":"7","key":"ref3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/AAC.41.7.1413","article-title":"Assessment of the pharmacodynamic properties of antimalarial drugs in vivo","volume":"41","author":"NJ White","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1086\/432011","article-title":"A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria","volume":"41","author":"EA Ashley","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1086\/425015","article-title":"Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand","volume":"190","author":"EA Ashley","year":"2004","journal-title":"J Infect Dis"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1086\/344647","article-title":"Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria","volume":"35","author":"MB Denis","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2125.2003.01962.x","article-title":"Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria","volume":"57","author":"H Karunajeewa","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"9402","key":"ref8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(03)15163-X","article-title":"Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial","volume":"363","author":"TH Tran","year":"2004","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2875-7-9","article-title":"How antimalarial drug resistance affects post-treatment prophylaxis","volume":"7","author":"NJ White","year":"2008","journal-title":"Malar J"},{"issue":"260","key":"ref10","doi-asserted-by":"crossref","first-page":"260ra147","DOI":"10.1126\/scitranslmed.3005311","article-title":"Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention","volume":"6","author":"M Bergstrand","year":"2014","journal-title":"Sci Transl Med"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1128\/AAC.05877-11","article-title":"Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria","volume":"56","author":"KM Lwin","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pt.2008.01.006","article-title":"Simplified antimalarial therapeutic monitoring: using the day-7 drug level?","volume":"24","author":"NJ White","year":"2008","journal-title":"Trends Parasitol"},{"key":"ref13","unstructured":"Sigma-Tau. Application for inclusion of dihydroartemisinin plus piperaquine (DHA\/PPQ) fixed dose combination tablets in the 17th WHO Model List of Essential Medicines. 2010 Nov 15 [cited 2016 Dec 1]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/selection_medicines\/committees\/expert\/18\/applications\/D_Piperaquine.pdf\" xlink:type=\"simple\">http:\/\/www.who.int\/selection_medicines\/committees\/expert\/18\/applications\/D_Piperaquine.pdf<\/ext-link>."},{"key":"ref14","unstructured":"Beijing Holley-Cotec Pharmaceuticals. DUO-COTECXIN\/6T. 2015 [cited 2015 Dec 15]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/en.holleycotec.com\/products_detail\/&productId=29.html\" xlink:type=\"simple\">http:\/\/en.holleycotec.com\/products_detail\/&amp;productId=29.html<\/ext-link>."},{"key":"ref15","unstructured":"Beijing Holley-Cotec Pharmaceuticals. DUO-CORTECXIN\/9T. 2015 [cited 2015 Dec 15]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/en.holleycotec.com\/products_detail\/&productId=28.html\" xlink:type=\"simple\">http:\/\/en.holleycotec.com\/products_detail\/&amp;productId=28.html<\/ext-link>."},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"AM Dondorp","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"EA Ashley","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","article-title":"Dihydroartemisinin\u2013piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study","volume":"16","author":"C Amaratunga","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"e1001564","DOI":"10.1371\/journal.pmed.1001564","article-title":"The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data","volume":"10","year":"2013","journal-title":"PLoS Med"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"e8988","DOI":"10.1371\/journal.pone.0008988","article-title":"Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis","volume":"5","author":"I Carneiro","year":"2010","journal-title":"PLoS ONE"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"e6358","DOI":"10.1371\/journal.pone.0006358","article-title":"Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis","volume":"4","author":"J Zwang","year":"2009","journal-title":"PLoS ONE"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/AAC.00955-07","article-title":"Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand","volume":"52","author":"J Tarning","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1365-2125.2003.02004.x","article-title":"Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria","volume":"57","author":"TY Hung","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/clpt.2011.254","article-title":"Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria","volume":"91","author":"J Tarning","year":"2012","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1128\/AAC.02318-13","article-title":"Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria","volume":"58","author":"J Tarning","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1128\/AAC.49.6.2407-2411.2005","article-title":"Effects of a high-fat meal on the relative oral bioavailability of piperaquine","volume":"49","author":"IK Sim","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1128\/AAC.05756-11","article-title":"Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria","volume":"56","author":"J Tarning","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1475-2875-11-303","article-title":"Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development","volume":"11","author":"S Zaloumis","year":"2012","journal-title":"Malar J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/1475-2875-11-398","article-title":"A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan","volume":"11","author":"RM Hoglund","year":"2012","journal-title":"Malar J"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cpt.104","article-title":"Population pharmacokinetics of piperaquine in young Ugandan children treated with dihydroartemisinin-piperaquine for uncomplicated malaria","volume":"98","author":"NC Sambol","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.actatropica.2008.05.013","article-title":"The influence of food on the pharmacokinetics of piperaquine in healthy Vietnamese volunteers","volume":"107","author":"TN Hai","year":"2008","journal-title":"Acta Trop"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1128\/AAC.00279-11","article-title":"A small amount of fat does not affect piperaquine exposure in patients with malaria","volume":"55","author":"A Annerberg","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/AAC.00555-07","article-title":"Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria","volume":"52","author":"HA Karunajeewa","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"c221","DOI":"10.1136\/bmj.c221","article-title":"Meta-analysis of individual participant data: rationale, conduct, and reporting","volume":"340","author":"RD Riley","year":"2010","journal-title":"BMJ"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1128\/AAC.00486-07","article-title":"Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria","volume":"51","author":"RN Price","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","unstructured":"WorldWide Antimalarial Resistance Network. The WWARN project terms of submission. 2013 Jun [cited 2015 Sep 19]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.wwarn.org\/sites\/default\/files\/attachments\/documents\/TermsOfSubmission.pdf\" xlink:type=\"simple\">http:\/\/www.wwarn.org\/sites\/default\/files\/attachments\/documents\/TermsOfSubmission.pdf<\/ext-link>."},{"key":"ref37","unstructured":"WorldWide Antimalarial Resistance Network. Data management and statistical analysis plan (DMSAP) version 1.0. Pharmacology module. 2011 Jun 23 [cited 2016 Dec 1]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.wwarn.org\/sites\/default\/files\/PharmacologyDMSAP.pdf\" xlink:type=\"simple\">http:\/\/www.wwarn.org\/sites\/default\/files\/PharmacologyDMSAP.pdf<\/ext-link>."},{"key":"ref38","unstructured":"WorldWide Antimalarial Resistance Network. Clinical module: data management and statistical analysis plan version 1.2. 2012 May 25 [cited 2016 Dec 1]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.wwarn.org\/sites\/default\/files\/ClinicalDMSAP.pdf\" xlink:type=\"simple\">http:\/\/www.wwarn.org\/sites\/default\/files\/ClinicalDMSAP.pdf<\/ext-link>."},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"e26005","DOI":"10.1371\/journal.pone.0026005","article-title":"Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast","volume":"6","author":"S Borrmann","year":"2011","journal-title":"PLoS ONE"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4269\/ajtmh.2008.79.620","article-title":"Pharmacokinetics of the antimalarial drug piperaquine in healthy Vietnamese subjects","volume":"79","author":"TC Nguyen","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/AAC.00927-08","article-title":"Pharmacokinetics and bioequivalence evaluation of two fixed-dose tablet formulations of dihydroartemisinin and piperaquine in Vietnamese subjects","volume":"53","author":"NT Chinh","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"ref42","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1128\/AAC.01717-08","article-title":"Pharmacokinetics and ex vivo pharmacodynamic antimalarial activity of dihydroartemisinin-piperaquine in patients with uncomplicated falciparum malaria in Vietnam","volume":"53","author":"DVH Nguyen","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1475-2875-11-217","article-title":"The efficacy and tolerability of artemisinin-piperaquine (Artequick\u00ae) versus artesunate-amodiaquine (Coarsucam<sup>TM<\/sup>) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam","volume":"11","author":"NX Thanh","year":"2012","journal-title":"Malar J"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4269\/ajtmh.2012.11-0410","article-title":"Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria","volume":"87","author":"I Adam","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"ref45","author":"SL Beal","year":"1992"},{"issue":"3","key":"ref46","first-page":"195","article-title":"Estimating population kinetics","volume":"8","author":"SL Beal","year":"1982","journal-title":"Crit Rev Biomed Eng"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cmpb.2003.11.003","article-title":"Perl-speaks-NONMEM (PsN)\u2014a Perl module for NONMEM related programming","volume":"75","author":"L Lindbom","year":"2004","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","article-title":"Xpose\u2014an S-PLUS based population pharmacokinetic\/pharmacodynamic model building aid for NONMEM","volume":"58","author":"EN Jonsson","year":"1999","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cmpb.2010.04.018","article-title":"Pira\u00f1a and PCluster: a modeling environment and cluster infrastructure for NONMEM","volume":"101","author":"RJ Keizer","year":"2011","journal-title":"Comput Methods Programs Biomed"},{"issue":"7","key":"ref50","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00228-010-0804-7","article-title":"Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria","volume":"66","author":"EA Ashley","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","article-title":"Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models","volume":"13","author":"M Bergstrand","year":"2011","journal-title":"AAPS J"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1208\/s12248-009-9133-0","article-title":"Importance of shrinkage in empirical Bayes estimates for diagnostics: problems and solutions","volume":"11","author":"RM Savic","year":"2009","journal-title":"AAPS J"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMc1403007","article-title":"Dihydroartemisinin-piperaquine failure in Cambodia","volume":"371","author":"DL Saunders","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"ref54","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/AAC.00835-15","article-title":"Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment","volume":"59","author":"R Leang","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref55","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1473-3099(15)70049-6","article-title":"Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study","volume":"15","author":"MD Spring","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12916-015-0301-z","article-title":"The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data","volume":"13","author":"MA Adjuik","year":"2015","journal-title":"BMC Med"},{"issue":"6","key":"ref57","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S1473-3099(15)70024-1","article-title":"The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data","volume":"15","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1038\/psp.2014.29","article-title":"Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with Plasmodium vivax malaria in Thailand","volume":"3","author":"J Tarning","year":"2014","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"6","key":"ref59","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1128\/AAC.06232-11","article-title":"Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria","volume":"56","author":"S Salman","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref60","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00228-005-0084-9","article-title":"Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects","volume":"62","author":"D Roshammar","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"ref61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2133\/dmpk.24.25","article-title":"Mechanistic basis of using body size and maturation to predict clearance in humans","volume":"24","author":"BJ Anderson","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"issue":"5","key":"ref62","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/sj.clpt.6100327","article-title":"Development of CYP2D6 and CYP3A4 in the first year of life","volume":"83","author":"TN Johnson","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.pharmtox.48.113006.094708","article-title":"Mechanism-based concepts of size and maturity in pharmacokinetics","volume":"48","author":"BJ Anderson","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"10","key":"ref64","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1128\/AAC.02667-14","article-title":"Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval","volume":"58","author":"J Manning","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T14:49:30Z","timestamp":1589726970000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002212"}},"subtitle":[],"editor":[{"given":"Clara","family":"Menendez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,10]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002212","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,10]]}}}